Company Filing History:
Years Active: 2017-2019
Title: Sharareh Salar Behzadi: Innovator in Pharmaceutical Composition
Introduction
Sharareh Salar Behzadi is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in developing taste-masked oral compositions. With a total of 2 patents, his work focuses on improving drug delivery systems.
Latest Patents
One of his latest patents is for a taste-masked oral pharmaceutical composition. This invention provides coated particles that contain a taste-masked drug substance. The particles consist of a core with the agglomerated active ingredient and a coating made of a triglyceride and a surfactant. These particles exhibit rapid drug release and a stable release profile. Additionally, the invention includes a hot-melt coating method for manufacturing such particles, allowing for the coating of core particles at moderate temperatures to prevent the degradation of thermolabile active ingredients.
Another significant patent by Behzadi is for an oral pharmaceutical composition comprising taste-masked N-acetylcysteine. Similar to his previous invention, this patent provides coated particles with taste-masked N-acetylcysteine. The particles consist of a core with the active ingredient and a coating of triglyceride and surfactant. They also demonstrate rapid drug release and a stable release profile, along with a hot-melt coating method for their production.
Career Highlights
Sharareh Salar Behzadi is currently associated with Hermes Arzneimittel GmbH, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in enhancing the effectiveness of drug formulations.
Collaborations
Behzadi collaborates with several professionals in his field, including Karin Becker and Detlev Haack. These collaborations contribute to the advancement of pharmaceutical technologies and innovations.
Conclusion
Sharareh Salar Behzadi is a prominent inventor whose work in taste-masked pharmaceutical compositions has the potential to significantly improve patient compliance and drug efficacy. His contributions to the field are noteworthy and continue to influence pharmaceutical development.